Main Article Content

Authors

Objective: In Colombia, from 2000 to 2012, a progressive increase in resistance to beta-lactams and quinolones was described in isolates of Salmonella sp. As of this date, the evolution of resistance rates in the country is unknown. The objective of this study is to describe the susceptibility profile from 2014 to 2017, as well as to evaluate the association between the clinical and sociodemographic characteristics of the population with the resistance patterns of Salmonella sp. Materials and methods: The study is a cross-sectional study between 2014 and 2017 at the Fundación Cardioinfantil, in patients over 18 years of age with Salmonella sp, in any type of biologic sample. Results: The authors found 60 cases, no isolate was resistant to quinolones. One showed resistant to ampicillin, and another one was characterized as amp-C; 95% had a usual susceptibility profile. No association was found between the variables studied and the presence of resistance. Conclusion: The results may reflect a change in the susceptibility profile of Salmonella sp in Colombia, with a decrease in resistance to betalactams and quinolones as of 2014; however, a larger population sample is required to corroborate this hypothesis.
Pérez Ardila, M. A., Noreña, I., Millán, H. A., Naranjo, J. A., Castellanos, J., Ladino, L., … Duarte, L. (2020). Resistance Profile of Salmonella SP During a Period of Three Years in a Hospital of Colombia. Revista Ciencias De La Salud, 18(1), 108–118. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.8768

Haselbeck AH, Panzner U, Im J, Baker S, Meyer CG, Marks F. Current perspectives on invasive nontyphoidal Salmonella disease. Curr Opin Infect Dis. 2017;30(5):498-503. Doi: 10.1097/QCO.0000000000000398

Uche IV, MacLennan CA, Saul A. A Systematic review of the incidence, risk factors and case fatality rates of invasive nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014). PLoS Negl Trop Dis. 2017;11(1): 1-28. Doi: 10.1371/journal.pntd.0005118

Marks F, von Kalckreuth V, Aaby P, Adu-Sarkodie Y, El Tayeb MA, Ali M, et al. Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study. Lancet. Glob. Heal. 2017;5(3):310-23. Doi: 10.1016/S2214-109X(17)30022-0

Crump JA, Mintz ED. Global trends in typhoid and paratyphoid Fever. Clin. Infect. Dis. 2010;50(2):241-6. Doi: 10.1086/649541

Instituto Nacional de Salud de Colombia. Fiebre tifoidea y paratifoidea Colombia. [Internet] 2017 [Acceso 29 May 2019]. Disponible en: https://www.ins.gov.co/buscador-eventos/Informesdeevento/FIEBRE%20TIFOIDEA%20Y%20PARATIFOIDEA%202017.pdf

Ohn W, Hendriksen RS, Mikoleit ML, Keddy KH, RLO. Typhoid Fever. Lancet. 2015;385:1136-45. Doi: 10.1016/S0140-6736(13)62708-7

De Toro M, Seral C, Rojo-Bezares B, Torres C, Castillo FJ, Sáenz Y. Resistencia a antibióticos y factores de virulencia en aislados clínicos de Salmonella enterica ଝ. Enferm Infecc Microbiol Clin. 2014;32(1):4-10. Doi: 10.1016/j.eimc.2013.03.006

Capalonga R, Ramos RC, Both JMC, Soeiro MLT, Longaray SM, Haas S, et al. Salmonella serotypes, resistance patterns, and food vehicles of salmonellosis in southern Brazil between 2007 and 2012. J Infect Dev Ctries. 2014;8(7):811-7. Doi: 10.3855/jidc.3791

Kuang D, Zhang J, Xu X, Shi W, Chen S, Yang X, et al. Emerging high-level cipro fl oxacin resistance and molecular basis of resistance in Salmonella enterica from humans, food and animals. Int J Food Microbiol. 2018;280:1-9. Doi: 10.1016/j.ijfoodmicro.2018.05.001

Medalla F, Gu W, Mahon BE, Judd M, Folster J, Griffin PM, et al. Estimated Incidence of Antimicrobial Drug-Resistant Nontyphoidal Salmonella Infections, United States, 2004-2012. Emerg Infect Dis. 2016;23(1):29-37. Doi: 10.3201/eid2301.160771

Instituto Nacional de Salud de Colombia. Características de los aislamientos de Salmonella spp en Colombia. Resultados de la vigilancia 2003-2013. [Internet] 2013 [Acceso 29 May 2019]. Disponible en: https://www.ins.gov.co/buscador-eventos/Informacin%20de%20laboratorio/Informe%20Vigilancia%20por%20laboratorio%20de%20Salmonella%20spp%202000-2013.pdf

Wayne, PA. Clinical and laboratory standards institute. Performance Standards for Antimicrobial Susceptibility Testing. 29a edición. CLSI supplement M100. CLSI, 2019.

Vasoo S, Mrcp M, Pharmd JNB, Tosh PK. Emerging issues in gram-negative Bacterial resistance. Mayo Clin Proc [Internet]. 2015;90(3):395-403. Doi: 10.1016/j.mayocp.2014.12.002

Navarro F, Calvo J, Cantón R, Fernández-Cuenca F. Detección fenotípica de mecanismos de resistencia en microorganismos gramnegativos. Enferm Infecc Microbiol Clin. 2011;29(7):524-34.

Frasson I, Bettanello S, De Canale E, Richter SN, Palu G. Serotype epidemiology and multidrug resistance patterns of Salmonella enterica infecting humans in Italy. Gut Pathog. 2016;8:26. Doi: 10.1186/s13099-016-0110-8

Horan TC, Andrus M, Dudeck MA. cdc/nhsn surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32.

Thompson CN, Karkey A, Dongol S, Arjyal A, Wolbers M, Darton T, et al. Treatment response in enteric fever in an era of increasing antimicrobial resistance: an individual patient data analysis of 2092 participants enrolled into 4 randomized, controlled trials in Nepal. Clin Infect Dis. 2017;64(11):1522-31. Doi: 10.1093/cid/cix185

Luo Y, Yi W, Yao Y, Zhu N, Qin P. Characteristic diversity and antimicrobial resistance of Salmonella from gastroenteritis. J Infect Chemother [Internet]. 2018;24(4):251-5. Doi: 10.1016/j.jiac.2017.11.003

Downloads

Download data is not yet available.

Similar Articles

1 2 3 4 5 6 7 8 > >> 

You may also start an advanced similarity search for this article.